PACB Stock Analysis: Buy, Sell, or Hold?
PACB - Pacific Biosciences of California, Inc.
$1.35
0.03 (2.27%)
▲
5d:
-1.46%
30d:
+20.54%
90d:
-2.17%
BUY
MODERATE Confidence
Analysis Updated: Jun 16, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When PACB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: PACB shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: PACB shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: PACB is currently trading at $1.35, which is considered fair relative to its 30-day fair value range of $1.21 to $1.49.
Technical Outlook: Technically, PACB is in a downtrend. Immediate support is located at $1.25, while resistance sits at $1.77.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.46 (+82.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PACB is in a downtrend. Immediate support is located at $1.25, while resistance sits at $1.77.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.46 (+82.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.21 -
$1.49
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 82.1% below Wall St target ($2.46)
Trading Range Analysis
30-Day Trading Range
$1.21 -
$1.49
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.25
Resistance Level
$1.77
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.40
Wall Street Target
$2.46
(+82.1%)
Revenue Growth (YoY)
0.1%
Profit Margin
-80.3%
Share & Embed Analysis
Last updated: June 16, 2026 8:34 PM ET
Data refreshes hourly during market hours. Next update: 9:34 PM
Data refreshes hourly during market hours. Next update: 9:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PACB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Christian O Henry
SELL
12497 shares
2026-03-03
Michele Farmer
SELL
2979 shares
2026-03-03
Oene Mark Van
SELL
6504 shares
2026-03-03
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 62 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 58 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 62 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 61 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
Advanced PACB Option Strategies
Professional options setups generated by AI based on today's PACB price and gamma walls.
